Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Lipson, Doron

Class:Id	Person:6800566
_displayName	Lipson, Doron
_timestamp	2015-09-29 16:48:23
created	[InstanceEdit:6800565] Rothfels, Karen, 2015-09-29
firstname	Doron
initial	D
surname	Lipson
(author)	[LiteratureReference:6800632] BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition [LiteratureReference:8852962] Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma [LiteratureReference:9647018] Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies [LiteratureReference:9700301] Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies [LiteratureReference:9711768] Kinase fusions are frequent in Spitz tumours and spitzoid melanomas [LiteratureReference:9713415] Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
[Change default viewing format]

No pathways have been reviewed or authored by Lipson, Doron (6800566)